vTv Therapeutics Inc. - VTVT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.0% | 198,237 | View |
| Mar 27, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.0% | 198,237 | View |
| Mar 27, 2026 | SCHEDULE 13G | Israel A. Englander | 5.0% | 198,237 | View |
| Dec 09, 2025 | SCHEDULE 13D/A | — | 9.9% | — | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 8.4% | 345,926 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 8.4% | 345,926 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Invus Global Management, LLC | 8.4% | 345,926 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Siren, L.L.C. | 8.4% | 345,926 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 1.2% | 47,172 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 1.2% | 47,172 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Ulys, L.L.C. | 1.2% | 47,172 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Raymond Debbane | 9.4% | 393,098 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.